Adrenal incidentalomas and the metabolic syndrome - Are there any differences between adenoma and hyperplasia?

Neoplasma

Volumn 53, Issue 4, 2006, Pages 324-327

  Lazurova I ^a   Dudasova D ^a   Wagnerova H ^a   Dravecka I ^a   Petrasova D ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Adrenal adenoma; Adrenal hyperplasia; Ferritin; Insulin resistance

Indexed keywords

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; SYMPTOMATOLOGY;

EID: 33746304805     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. ANGELI A, TERZOLO M. Adrenal incidentaloma - a modern disease with old complications. J Clin Endocrinol Metab 2002; 87(11): 4869-4871.
2. TAUCHMANOVA L, ROSSI R, BIONDI B, PULCRANO M, NUZZO V et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002; 87: 4872-4878.
3. CATARGI B, RIGALLEAU V, POUSSIN A, RONCI-CHAIXN, BEX V et al. Occult Cushing's syndrome in Type-2 Diabetes. J Clin Endocrinol Metab 2003; 88: 5808-5813.
4. VIERHAPPER H, HEINZE G, GESSL A, EXNER M. Adrenocortical tumors: prevalence of impaired glucose tolerance test and of "paradoxical rise" of cortisol during an oral glucose tolerance test. Exp Clin Endocrinol Diabetes 2003; 111: 415-420.
5. MIDORIKAWA S, SANADA H, HASHIMOTO S, SUZUKI T, WATANABE T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol 2001; 54: 797-804.
6. REINCKE M, FASSNACHT M, VATJ S, MORA P, ALLOLIO B. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocrinol Res 1996; 22: 757-761.
7. TERZOLO M, PIA A, ALI A, OSELLA G, REIMONDO G et al. Adrenal incidentaloma: anew cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87: 998-1003.
8. TERZOLO M, REIMONDO G, BOVIO S, ANGELI A. Subclinical Cushing's syndrome. Pituitary 2004; 7: 217-223.
9. FERNANDEZ-REAL, JM, RICART ENGEL W, SIMO R, SALINAS I, WEBB SM. Study of glucose tolerance in consecutive patients harboring incidental adrenal tumors. Clin Endocrinol 1998; 49: 53-61.
10. PERRY CG, SPIERS A, CLELAND SJ, LOWE GDO, PETRIE JR et al. Glucocorticoids and insulin sensitivity: Dissociation of insulins metabolic and vascular actions. J Clin Endocrinol Metab 2003; 88: 6008-6014.
11. WANG M. The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Metab 2005; 2: 1-14.
12. CAPLAN RH, STRUTT PJ, WICKUS GG. Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg 1994; 129: 291-296.
13. JEHN M, CLARK JM, GUALLAR F. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004; 27: 2422-2428.
14. VLASAKOVA Z, PELIKANOVA T, KAZDOVA L, LANSKA U. Serum ferritin, LDL oxidation and risk factors for atherogenesis in healthy offspring of hypertensive patients. Vnitř Lék 2002;48: 105-111 (in Czech).
15. FERNANDEZ-REAL JM, RICART-ENGEL W, ARROYO E, BALANCA R, CASANITJIANA-ABELLA R et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998; 21: 62-68.
16. TSENG M, GREENBERG ER, SANDLER RS, BARON JA, HARLE RW et al. Serum ferritin concentration and recurrence of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2000; 9: 625-630.